News
The rise of GLP-1 drugs is a reminder that we must move beyond the simple equation of thinness as health and value. These ...
18h
TAG24 on MSNWeight loss jabs linked to lower dementia and stroke riskWeight loss jabs may offer a protective effect against dementia and stroke, according to a new study.People with type 2 diabetes and obesity who are taking the drugs are also less likely to die ...
A new study has found that an anti-obesity drug called tirzepatide, which is sold under the names Mounjaro for diabetes and ...
Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for ...
People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...
Wegovy, India’s first injectable semaglutide for chronic weight management, recorded Rs 2.54 crore in sales in June ...
Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new study.
Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious ...
A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
PRINCETON, NJ, USA I July 15, 2025 I Palatin Technologies, Inc. (OTCQB: PTNT), a biopharmaceutical company developing first-in-class medicines based on ...
The game-changing weight loss jabs have ushered in a new era in the war on obesity, but have also been linked to other health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results